COMPASS BIOINFORMATICS INC.
Update：2023/06/12
Industries
Main Industry
Biotechnology
Main Product/Service
InheriNextR is an AI-powered NGS analysis platform by Compass Bioinformatics, FDA Class I SaMD certified. Its modular design automates and streamlines the entire workflow—from sequencing data to clinical reporting—enabling fast, accurate, and standardized genetic interpretation.
Founded Year
2015
Unified Business No.
24727426
Status
Active
Number of Employees
0
Total Paid-in
Capital
206,000,000 (NT$)
Location of Company
Taiwan
, Hsinchu City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE."
Exclusive content for members
Members-only content. Please log in to access.
Introduction
Compass Bioinformatics is committed to becoming a global leader in Software as a Medical Device (SaMD) for multi-omics. We are a team of clinicians, AI data scientists, bioinformatics experts, and system developers across USA, Japan, and Taiwan.
